# Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery

> **NCT00541073** · PHASE2 · COMPLETED · sponsor: **Centre Oscar Lambret** · enrollment: 60 (estimated)

## Conditions studied

- Malignant Mesothelioma

## Interventions

- **DIETARY_SUPPLEMENT:** vitamin B12
- **DRUG:** cisplatin
- **DRUG:** pemetrexed disodium
- **GENETIC:** gene expression analysis
- **OTHER:** laboratory biomarker analysis
- **OTHER:** pharmacological study

## Key facts

- **NCT ID:** NCT00541073
- **Lead sponsor:** Centre Oscar Lambret
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2011-05
- **Final completion:** —
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2011-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00541073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00541073, "Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00541073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*